Carmat SA (ALCAR.PA)
9 Dec 2016
Latest Key Developments (Source: Significant Developments)
Carmat SA:Carmat completes its 50.0 million euros reserved capital increase.1,349,159 new shares issued should be listed on Alternext Paris market from April 28. Full Article
Carmat SA:Announces capital increase plan for minimum of 50.0 million euros.Pool of strategic investors will fully subscribe 50.0 million euro equity financing.Airbus is taking 22.0 pct; Cornovum (Bpifrance & french state) is taking 34.0 pct. Full Article
Carmat SA:Says third patient, who was implanted with a Carmat prosthesis on April 8, died on morning of Dec. 18.Says analyses carried out do not show that prosthesis was involved in patient's death.Says is continuing feasibility study. Full Article
Carmat SA:Presents first elements of analysis of CARMAT bioprosthesis implanted in second patient.Patient lived virtually normal life with CARMAT prosthesis for nine months.Initial analysis following this relatively long period shows the prosthesis' biocompatibility with organism and blood.Design's fundamentals have thus been corroborated. Full Article
PARIS Shares in artificial heart maker Carmat slumped on Thursday after France's national drugs agency ordered it to suspend further implants following the death of a patient in October.